Michael J Kozal MD
Professor of Medicine (AIDS); Chief Section of Infectious Diseases VA CT Healthcare System; Director Yale HIV Clinical Trials; Acting Chief, Medical Service VACHS & Vice Chair, VA Medical Service for the Yale Dept. of Internal Medicine
Departments & Organizations
Genetic determinants of HIV and Hepatitis C drug resistance; New technologies to detect low abundance drug resistant viral variants more...
- M.D., University of Nebraska, 1988
- Geretti AM, Paredes R, and Kozal MJ. Transmission of HIV drug resistance: lessons from sensitive screening assays. Current Opinion in Infectious Diseases, Curr Opin Infect Dis. 2014 Dec 9. [Epub ahead of print]; 2015 Feb;28(1):23-30. PMID:25501541
- Shaili Gupta, Max Lataillade, Tassos Kyriakides, Jennifer Chiarella, Elizabeth P St John, Suzin Webb, Elizabeth A Moreno, Birgitte B Simen, and Michael J Kozal. Low-frequency NNRTI-resistant HIV-1 Variants and Correlation to Mutational Load in Antiretroviral-naïve Subjects. Viruses 2014, 6, 3428-3437; PMID:25256391 doi:10.3390/v6093428
- Zou Xiaobai, Chen Xi, Tian H, Williams AB, Wang H, He J, Zhen J, Chiarella J, and Kozal MJ. Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China. PLoS One. 2014 Jun 4;9(6):e98740. doi: 10.1371/journal.pone.0098740